InflaRx NV buy Guggenheim
Start price
05.04.23
/
50%
€4.97
Target price
05.04.24
€7.32
Performance (%)
-71.61%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Guggenheim for InflaRx NV performed very badly with a performance of -71.61%. Guggenheim has a follow-up prediction for InflaRx NV where he still thinks InflaRx NV is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| InflaRx NV | -5.790% | -5.790% | -49.507% |
| iShares Core DAX® | 1.614% | -2.653% | 20.929% |
| iShares Nasdaq 100 | 2.191% | -0.704% | 9.441% |
| iShares Nikkei 225® | -0.459% | -3.230% | 12.630% |
| iShares S&P 500 | 2.385% | 0.248% | 3.543% |
Comments by Guggenheim for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating. They now have a $8.00 price target on the stock.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten